[1] [14] Long-term success with tirzepatide depends on using the medication as a tool to support sustainable lifestyle changes rather than relying solely on appetite suppression for weight management
On July 7, 2026, Trutakna (atacicept) became the first and only approved therapy that blocks both BAFF and APRIL the two cytokines that sit furthest upstream in IgA nephropathy, driving B cells to produce the abnormal antibody that deposits in and damages the kidneys
Tell your doctor about all dietary supplements and non-prescription medications that you are taking
MT-1 is examined in studies involving melanogenesis, ultraviolet response, pigmentation pathways, and cellular photobiology
Retatrutide is an investigational peptide medicine currently under clinical evaluation for the treatment of obesity and overweight-related conditions
Agbai states that she follows FDA guidelines when prescribing Wegovy, which means only prescribing it to children 12 and above